We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Vision-Based Blood Test System Gives Accurate Results

By LabMedica International staff writers
Posted on 29 Nov 2012
A proprietary technological platform for Point of Care Testing (POCT) has been developed that will give blood results in 15 minutes. More...


The system combines cameras, proprietary software, and easy to use Digital Video Disc (DVD)-styled test cartridges, uses only a small drop of blood and compared to similar devices in the market, it is cost-efficient, fast, accurate, reliable, and uniquely capable of multiparameter testing.

In the Spinit testing process, the technician places a small blood sample onto the test panel cartridge and all the blood sample preparation is done automatically. The sample flows through a series of microfluidic structures, where different operations are made including separation of blood components and mixing with other solutions. After preparation, the sample is directed to a number of detection zones on the cartridge.

Each detection zone includes a biological recognition layer (BRL) developed using antibody fragments attached on a gold surface. By using different antibody fragments and immobilization strategies, the gold layer will act as a selective trap for a specific blood biomarker. When the patient's blood passes through the BRL, the targeted biomarker binds to the antibody fragments. It is the concentration of trapped biomarkers that the device is testing.

The Spinit System (Point Grey; Richmond, BC, Canada) uses Surface Plasmon Resonance (SPR), a well-established spectrometry technique, to optimally measure the concentration of biomarkers. This is done by measuring the refractive index of light reflecting off the gold's surface after exposure to the patient's blood sample, so that the higher the concentration would result in the lower index. There is an optical module that when the cartridge is spinning, a camera is triggered when the phototransistor behind the semi-opaque mirror detects a reflection coming from the detection zone. The camera is used to acquire 3,000 images of each detection zone over a 10-minute period.

The Spinit will be released later in 2012 and the first cartridge will measure C - reactive protein (CRP). CRP is an acute phase protein actively circulating in the body during an inflammatory response. CRP is a standard test parameter, important in treating bacterial infections, significantly decreasing the chances of inadequately prescribing antibiotics and more effectively treating other infections and inflammatory conditions. Future tests to be added include total blood count, a diabetes panel, and a cardiac panel.

Related Links:
Point Grey



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.